Literature DB >> 10355663

Management of chronic myeloid leukemia during pregnancy with leukapheresis.

F J Strobl1, K V Voelkerding, E P Smith.   

Abstract

We describe the successful treatment of a pregnant patient with chronic myelogenous leukemia in chronic phase by using only leukapheresis. Following 20 leukapheresis procedures initiated during the 13th week of gestation and performed over approximately 7 weeks, the patients white blood cell count dropped from 242,000/microl to 19,300/microl. The WBC remained stable over the ensuing 17 weeks until the time of delivery. The patient gave birth by cesarean section to a healthy 2,640 g boy at 37.5 weeks of gestation. This is the second report of the successful use of leukapheresis alone for chronic myelogenous leukemia in chronic phase during the first half of pregnancy. We conclude that where leukapheresis is available, it may provide an alternative treatment to chemotherapy or alpha-interferon, especially in light of their potential teratogenic and leukemogenic side-effects.

Entities:  

Mesh:

Year:  1999        PMID: 10355663     DOI: 10.1002/(sici)1098-1101(1999)14:1<42::aid-jca8>3.0.co;2-2

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  9 in total

Review 1.  Pregnancies in patients with chronic myeloid leukemia in the era of imatinib.

Authors:  Liang-Piu Koh; Devendra Kanagalingam
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

Review 2.  Management of chronic myeloid leukemia in the setting of pregnancy: when is leukocytapheresis appropriate? A case report and review of the literature.

Authors:  Elizabeth M Staley; Sierra C Simmons; Alexander Z Feldman; Robin G Lorenz; Marisa B Marques; Lance A Williams; X Long Zheng; Huy P Pham
Journal:  Transfusion       Date:  2017-12-11       Impact factor: 3.157

3.  Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy.

Authors:  Monika Conchon; Sabri S Sanabani; Mariana Serpa; Mafalda M Y Novaes; Luciana Nardinelli; Patrícia B Ferreira; Pedro Enrique Dorliac-Llacer; Israel Bendit
Journal:  Adv Hematol       Date:  2010-03-07

4.  A case of chronic myelogenous leukemia in pregnancy characterized by a complex translocation t(9;22;11)(q34;q11.2;q13).

Authors:  Surachit Kumar; Mariya Apostolova; Paul V Woolley
Journal:  Hematol Rep       Date:  2011-11-21

Review 5.  Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.

Authors:  Hussain Alizadeh; Hassan Jaafar; Béla Kajtár
Journal:  Ann Saudi Med       Date:  2015 Nov-Dec       Impact factor: 1.526

6.  Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study.

Authors:  Monika Conchon; Sabri S Sanabani; Israel Bendit; Fernanda Maria Santos; Mariana Serpa; Pedro Enrique Dorliac-Llacer
Journal:  J Hematol Oncol       Date:  2009-10-06       Impact factor: 17.388

Review 7.  The treatment of hematologic malignancies in pregnancy.

Authors:  C Vandenbriele; D Dierickx; F Amant; M Delforge
Journal:  Facts Views Vis Obgyn       Date:  2010

8.  Outcome of Pregnancy in the Era of PEGylated Interferon-α2a in Females with Chronic Myeloid Leukemia: An Experience from Qatar.

Authors:  Mohammad Abu-Tineh; Nancy Kassem; Mohammad Abdul-Jaber Abdulla; Omar Mohammad Ismail; Khaldun Obeidat; Rola Ghasoub; Mohamed A Yassin
Journal:  Case Rep Oncol       Date:  2020-03-24

9.  Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.

Authors:  Irappa Madabhavi; Malay Sarkar; Mitul Modi; Nagaveni Kadakol
Journal:  J Glob Oncol       Date:  2019-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.